−14.36 MUSD
250.00 KUSD
38.51 M
About Ayala Pharmaceuticals, Inc.
Sector
CEO
Kenneth A. Berlin
Website
Headquarters
Monmouth Junction
Employees (FY)
15
Founded
2017
ISIN
US0076244062
FIGI
BBG000KVFDD9
Ayala Pharmaceuticals, Inc. is a clinical-stage oncology company, which engages in developing and commercializing small molecule therapeutics for patients suffering from rare tumors and aggressive cancers. Its lead candidates are the oral gamma secretase inhibitor, AL102, for desmoid tumors, and aspacytarabine (BST-236), a novel proprietary anti-metabolite for first line treatment in unfit acute myeloid leukemia. The company was founded in November 2017 and is headquartered in Monmouth Junction, NJ.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of ADXS is 0.5700 USD — it has decreased by 11.70% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Ayala Pharmaceuticals, Inc. stocks are traded under the ticker ADXS.
Ayala Pharmaceuticals, Inc. is going to release the next earnings report on May 16, 2024. Keep track of upcoming events with our Earnings Calendar.
ADXS stock is 29.10% volatile and has beta coefficient of 2.43. Check out the list of the most volatile stocks — is Ayala Pharmaceuticals, Inc. there?
ADXS earnings for the last quarter are −1.32 USD whereas the estimation was −1.32 USD which accounts for 0% surprise. Estimated earnings for the next quarter are −1.27 USD. See more details about Ayala Pharmaceuticals, Inc. earnings.
Ayala Pharmaceuticals, Inc. revenue for the last quarter amounts to 19.69 M USD despite the estimated figure of 9.75 M USD. In the next quarter revenue is expected to reach 500.00 K USD.
Yes, you can track Ayala Pharmaceuticals, Inc. financials in yearly and quarterly reports right on TradingView.
ADXS stock has fallen by 14.67% compared to the previous week, the month change is a 5.00% fall, over the last year Ayala Pharmaceuticals, Inc. has showed a 55.12% decrease.
Today Ayala Pharmaceuticals, Inc. has the market capitalization of 27.52 M, it has increased by 4.37% over the last week.
No, ADXS doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, ADXS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Ayala Pharmaceuticals, Inc. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 19, 2024, the company has 15.00 employees. See our rating of the largest employees — is Ayala Pharmaceuticals, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Ayala Pharmaceuticals, Inc. technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Ayala Pharmaceuticals, Inc. stock shows the sell signal. See more of Ayala Pharmaceuticals, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.